Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07QNN
|
|||
| Former ID |
DNC005569
|
|||
| Drug Name |
N-Cyclohexyl-2-phenyl-acetamide
|
|||
| Synonyms |
N-Cyclohexyl-2-phenylacetamide; N-Cyclohexylphenylacetamide; Acetamide, N-cyclohexyl-2-phenyl-; 10264-08-1; EINECS 233-602-9; N-Cyclohexylamide of phenylacetic acid; UNII-VY9DC35P8W; NSC 126805; BRN 2102004; VY9DC35P8W; MLS002919901; CHEMBL191355; SMR001797500; N-Cyclohexyl-2-phenyl-acetamide; NSC126805; N-Cyclohexylbenzeneacetamide; AC1L33JD; MLS006026924; 4-12-00-00045 (Beilstein Handbook Reference); Benzeneacetamide,N-cyclohexyl-; SCHEMBL3397254; CTK4A1359; DTXSID20145427; MolPort-002-799-328; ZINC339690; STK031107; BDBM50167047
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H19NO
|
|||
| Canonical SMILES |
C1CCC(CC1)NC(=O)CC2=CC=CC=C2
|
|||
| InChI |
1S/C14H19NO/c16-14(11-12-7-3-1-4-8-12)15-13-9-5-2-6-10-13/h1,3-4,7-8,13H,2,5-6,9-11H2,(H,15,16)
|
|||
| InChIKey |
ZFEBPJQSSNUJGT-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 10264-08-1
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. J Med Chem. 2005 May 19;48(10):3621-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.